Catalyst Pharmaceuticals Inc (CPRX)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 727,632 660,941 608,655 561,412 387,881 348,548 375,294 333,661 300,421 270,041 241,092 220,221 206,831 198,661 188,944 178,651 169,598 156,628 111,201 99,676
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $727,632K)
= 0.00

The debt-to-capital ratio of Catalyst Pharmaceuticals Inc has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has no debt in its capital structure during the period under review. This signifies that Catalyst Pharmaceuticals Inc has been operating without relying on external borrowing to fund its operations, acquisitions, or expansions. A low or zero debt-to-capital ratio can be viewed positively by investors and creditors as it implies lower financial risk and potential for better financial stability. However, it is also essential to consider other financial ratios and factors to gain a holistic understanding of the company's financial health and performance.